Multiscale Analysis of Trauma
创伤的多尺度分析
基本信息
- 批准号:9264028
- 负责人:
- 金额:$ 75.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2021-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAcute Lung InjuryAgonistAlgorithmsAnimal ModelAntigensBehaviorBiochemicalBiochemistryBiologicalBiological AssayBiological MarkersBiological Neural NetworksBiologyBiomedical EngineeringBloodBlood CirculationBlood Coagulation DisordersBlood PlateletsBlood VesselsBlood VolumeBlood coagulationBlood specimenCardiacCase StudyCell DeathCell modelCellsCerealsClinicalClinical DataCoagulation ProcessComplementComplexComputer SimulationControlled StudyDNADataDatabasesDeep Vein ThrombosisDetectionDevelopmentDiagnosticDiffusionDoseElementsEndothelial CellsEndotheliumEventExposure toExtravasationFibrinolysisFunctional disorderGoalsHematologistHemorrhageHemostatic functionHistonesHormonalHumanIn VitroIndividualInjuryKineticsLifeLinkLiquid substanceMapsMeasurementMeasuresMediatingMedicalMethodsMicrofluidic MicrochipsMicrofluidicsModelingMusMuscleMutationOperative Surgical ProceduresOutputPathologicPathway interactionsPatient SimulationPatient-Focused OutcomesPatientsPennsylvaniaPeptide HydrolasesPerformancePharmacologyPlasmaPopulationProcessProductionReactionRecordsResearchRiskRuptureSafetyScanningScientistSepsisSeveritiesSideSignal PathwaySignal TransductionStimulusSurgeonTechniquesTestingThrombinThrombosisTimeTissue ModelTissuesTracerTrainingTransfusionTraumaTrauma patientUnited States National Institutes of HealthUniversitiesValidationVascular PermeabilitiesWhole BloodWhole OrganismWorkbasebiochemical modelclinical decision-makingcombinatorialcostcytokinedatabase designdesignendothelial dysfunctionexperimental studyhemodynamicshigh dimensionalityimprovedin vivoin vivo Modelinnovationintercellular cell adhesion moleculelaboratory experimentloss of functionmetermolecular scalemouse modelmulti-scale modelingneutrophilnovelpatient stratificationpressurepublic health relevancereceptorresponsesensorsimulationsyndecan
项目摘要
DESCRIPTION (provided by applicant): In response to PAR-15-085, the University of Pennsylvania and Princeton University have assembled an interdisciplinary team of bioengineers, computational scientists, trauma surgeons, and hematologists to develop a multiscale model of trauma. Better elucidation and quantitative measurement of blood reactions, platelet signaling, neutrophil signaling, and endothelial signaling pathways under hemodynamic conditions are directed at clinical needs in: (i) stratifying trauma induced coagulopathy (TIC) risks, (ii) improving the safety and efficacy of transfusion therapy, and (iii) identifying moleculr mechanisms that can be targeted pharmacologically or serve as improved biomarkers. Six specific aims are proposed: Aims 1 and 2 focus on the development of mechanistic and data-driven computer models of biochemical and cellular function relating to: protease cascades of coagulation, fibrinolysis, and complement assembly, as well as platelet, neutrophil and endothelial function. Aim 3 then develops a multiscale model of blood clotting and hemostatic function in a damaged blood vessel. The individual sub-models at the single cell level are combined into the unit vessel bleeding model which is related closely to laboratory experiments that test the functional performance of mouse and human patient blood under the extreme conditions of trauma. Aim 3 also involves microfluidic bleeding assays of human blood under diverse pathological conditions that explore bleeding scenarios involving combinatorial alterations of biochemistry and biology relevant to trauma. Aim 4 will implement "coarse projective integration" (CPI) to make prediction of the evolving systemic circulation and its interaction with a traumatized tissue where bleeding is quantified at the single cell to single vessel to tissue scale. These simulations are designed to validate an in silico trauma patient in order to stratify the risk of TIC. In Aim 5, the intensive use of fresh blood samples from trauma patients and annotated records from trauma patients will be part of the validation of the multiscale CPI algorithm. Key preliminary data demonstrates detection and quantification of platelet hypofunction in trauma patients. Aim 6 will utilize a novel in vivo mouse injury model to study bleeding and hemostasis in a calibrated model of trauma severity. This in vivo data will also be used to enhance the predictive capability of the multiscale model and to potentially identify biomarkers for stratifying TIC risks in humans. Also the mouse work emphasizes the use of novel fluorescent sensors developed specifically for this research. Overall, these aims represent the full integration of platelet, neutrophil, and endothelial signaling models with realistic and hierarchical hemodynamic/mass transport simulations that regulate bleeding and blood function at the various scales relevant to trauma.
描述(由适用提供):响应于15-085 PAR,宾夕法尼亚大学和普林斯顿大学组建了一个由生物工程师,计算科学家,创伤外科医生和血液学家组成的跨学科团队,以开发一种多叶的创伤模型。在血液动力学条件下的血液反应,血小板信号传导,中性粒细胞信号传导和内皮信号传导途径的更好阐明和定量测量指向血液动力学条件下的内皮信号传导途径。作为改进的生物标志物。提出了六个具体目的:目标1和2的侧重于开发生化和细胞功能的机械和数据驱动的计算机模型,该模型与:凝结,纤维蛋白溶解和补体组装的蛋白酶级联有关,以及血小板,中性粒细胞和内皮功能。 AIM 3然后在受损的血管中开发出血液凝结和止血功能的多尺度模型。单细胞水平的单个子模型合并为单位血管出血模型,该模型与实验室实验密切相关,这些实验在极端的创伤条件下测试了小鼠和人类患者血液的功能性能。 AIM 3还涉及在潜水病理条件下人类血液的微流体出血,探索出血情景涉及与创伤有关的生物化学和生物学的组合改变。 AIM 4将实施“粗糙的投射整合”(CPI),以预测不断发展的全身循环及其与受伤的组织的相互作用,在该组织中,单细胞将出血定量到单个容器至单血管至组织尺度。这些仿真旨在验证一名硅酸创伤患者的患者,以分层TIC的风险。在AIM 5中,大量使用创伤患者的新鲜血液样本以及创伤患者的注释记录将是对多尺度CPI算法验证的一部分。关键的初步数据表明,创伤患者的血小板功能功能低下的检测和定量。 AIM 6将利用一种新型的体内小鼠损伤模型来研究校准的创伤严重程度模型中的出血和止血。该体内数据还将用于增强多尺度模型的预测能力,并有可能识别生物标志物来分层人类的TIC风险。同样,小鼠的工作强调了专门为这项研究开发的新型荧光传感器的使用。总体而言,这些目标代表了血小板,中性粒细胞和内皮信号模型的完整整合,该模型具有逼真的和分层的血液动力学/质量传输模拟,这些模拟在与创伤有关的各种尺度上调节出血和血液功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT L DIAMOND其他文献
SCOTT L DIAMOND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT L DIAMOND', 18)}}的其他基金
Neonatal and Pediatric Platelet Function and Pharmacology
新生儿和儿童血小板功能和药理学
- 批准号:
9759659 - 财政年份:2018
- 资助金额:
$ 75.71万 - 项目类别:
Neonatal and Pediatric Platelet Function and Pharmacology
新生儿和儿童血小板功能和药理学
- 批准号:
9292339 - 财政年份:2015
- 资助金额:
$ 75.71万 - 项目类别:
Neonatal and Pediatric Platelet Function and Pharmacology
新生儿和儿童血小板功能和药理学
- 批准号:
8908392 - 财政年份:2015
- 资助金额:
$ 75.71万 - 项目类别:
Neonatal and Pediatric Platelet Function and Pharmacology
新生儿和儿童血小板功能和药理学
- 批准号:
9103240 - 财政年份:2015
- 资助金额:
$ 75.71万 - 项目类别:
Core C: Genomics and High Throughput Screening Core
核心 C:基因组学和高通量筛选核心
- 批准号:
8066104 - 财政年份:2010
- 资助金额:
$ 75.71万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
- 批准号:
10751760 - 财政年份:2024
- 资助金额:
$ 75.71万 - 项目类别:
Midlife cardiovascular stress physiology and preclinical cerebrovascular disease
中年心血管应激生理学与临床前脑血管疾病
- 批准号:
10720054 - 财政年份:2023
- 资助金额:
$ 75.71万 - 项目类别:
Predicting ECMO NeuroLogICal Injuries using mAchiNe Learning (PELICAN)
使用机器学习预测 ECMO 神经损伤 (PELICAN)
- 批准号:
10719312 - 财政年份:2023
- 资助金额:
$ 75.71万 - 项目类别:
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
米托醌/甲磺酸米托喹诺作为 Covid-19 的口服且安全的暴露后预防
- 批准号:
10727092 - 财政年份:2023
- 资助金额:
$ 75.71万 - 项目类别:
Development of a Neutrophil Degranulation Inhibitor to Treat ARDS
开发治疗 ARDS 的中性粒细胞脱颗粒抑制剂
- 批准号:
10697442 - 财政年份:2023
- 资助金额:
$ 75.71万 - 项目类别: